Nita Radhakrishnan on Challenges In Congenital Afibrinogenemia
Nita Radhakrishnan, Additional Professor and HOD, Department of Pediatric Hematology-Oncology, shared on LinkedIn:
”Recent publication from our center adds real-world data on the clinical spectrum and outcomes of congenital afibrinogenemia, highlighting severe bleeding risks, diagnostic delays, and ongoing health-system challenges— in resource-limited settings.
Strengthens the case for improved recognition, registries, and access to fibrinogen replacement therapy.”
Read the full article here.
Article: Clinical outcomes and health-system challenges in congenital afibrinogenemia: a single-centre prospective case series
Authors: Nita Radhakrishnan, Savitri Singh, Archit Pandharipande, Eby P. Baby, Hari Gaire
Stay updated on all scientific advances with Hemostasis Today.
-
Jan 22, 2026, 15:36We Must Roll Up Our Sleeves And Help: José Antonio García Erce on Plasma Donation
-
Jan 22, 2026, 15:10Jin Q Gives a Summary of 2025’s Most Impactful Cell and Gene Therapy Milestones
-
Jan 22, 2026, 14:57Nirav Dhanesha on CD14 Acting As A Functional Driver of DVT
-
Jan 22, 2026, 11:41Jamilla Goedegebuur and Colleagues on VTE Management in Case of PAD
-
Jan 22, 2026, 11:28Abdulrahman Katib on API-CAT Trial’s Evaluation of Apixaban Dosing
-
Jan 22, 2026, 11:19Bruno Odisio: Ablation Margins Are Software-Dependent
-
Jan 22, 2026, 10:38Pedro Perez: The VTE Market Is Clearly Entering Its Next Phase
-
Jan 22, 2026, 10:29Marvin Garcia Reyes Presents a Case of Aorto-Visceral and Aorto-Iliac Thrombosis
-
Jan 22, 2026, 10:16Mohamed Rawy Gives Clinical Tips for Management of Atrial Fibrillation